Skip to main content
Caplight Logo









Shanghai Refreshgene Technology Co., Ltd.

Shanghai Refreshgene Technology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://reforgene.com

Last Round

Series B

Dec 30, 2024

Total Funding Raised

$15.14M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Shanghai Refreshgene Technology Co., Ltd. is a biotechnology company that develops gene therapy drugs for the treatment of chronic and rare diseases, including ophthalmology, otology, cardiovascular, and tumor-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVviral vectorbiotechclinical-stage biotechnon-viral vectorretinal disease therapydual AAV vectorgenetic medicineCDMOcontract manufacturingrare disease treatmentgene delivery platformgenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Refreshgene Technology Co., Ltd. Comparables

Compare Shanghai Refreshgene Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Refreshgene Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exegenesis Bio
86%
Frontera Therapeutics
85%
Neurophth
85%

Shanghai Refreshgene Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 30, 2024
Early FundingApr 28, 2023
Series A ExtensionSep 16, 2021
Series ANov 2, 2020
AngelJan 19, 2020

Key People

Founding team and executive leadership

Junbin Liang

Founder and CEO

Founding Team

Jason Wang

Chief Financial Officer

Executive Team

Shanghai Refreshgene Technology Co., Ltd. Investors

Notable investors and investment history

Shanghai Refreshgene Technology Co., Ltd. investors
InvestorRounds
BioTrack CapitalSeries A Extension, Early Funding
Legend StarSeries A, Angel
Guangzhou Industrial Investment Holding GroupSeries B
YuanBio Venture CapitalSeries A Extension
Guangzhou Science and Technology Financial Innovation Investment HoldingSeries B
Sinovation VenturesSeries A Extension
Legend HoldingsAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 2002% MoM, from 45 to 946.

  • Dec 30, 2024

    Led by Guangzhou Industrial Investment Holding Group.

Shanghai Refreshgene Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Shanghai Refreshgene Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shanghai Refreshgene Technology Co., Ltd.'s valuation, stock price, and market status.

Is Shanghai Refreshgene Technology Co., Ltd. a public or private company?

Shanghai Refreshgene Technology Co., Ltd. is a private company.

What is the current stock price of Shanghai Refreshgene Technology Co., Ltd.?

Shanghai Refreshgene Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Shanghai Refreshgene Technology Co., Ltd. worth (valuation)?

Valuation information for Shanghai Refreshgene Technology Co., Ltd. is not publicly available.

Can I buy Shanghai Refreshgene Technology Co., Ltd. stock?

Shanghai Refreshgene Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Shanghai Refreshgene Technology Co., Ltd.'s last funding round?

Shanghai Refreshgene Technology Co., Ltd.'s most recent funding round was Series B on December 30, 2024.

Who are the main investors in Shanghai Refreshgene Technology Co., Ltd.?

Key investors in Shanghai Refreshgene Technology Co., Ltd. include Guangzhou Industrial Investment Holding Group, YuanBio Venture Capital, Guangzhou Yuexiu Industrial Investment Fund Management.

Will Shanghai Refreshgene Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Shanghai Refreshgene Technology Co., Ltd..

How can I track Shanghai Refreshgene Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Refreshgene Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2020
Last FundingDec 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?